alfresa -Alfresa Pharma Corporation-

For many people

For one person

As long as there are

Through the entire healthcare process, from diagnosis, to treatment, to prevention

Research and development, production, sales, Contract Manufacturing

From Japan to the world

From the world to Japan

For the health of all the world's people We are taking on the challenge of Unmet Medical Needs

2017/02/07: Summary of Consolidated Financial Statements for the Third Quarter Ended December 31, 2016”

2016/11/04: Summary of Consolidated Financial Statements for the Second Quarter Ended September 30, 2016

2016/08/04: Summary of Consolidated Financial Statements for the First Quarter Ended June 30, 2016

2016/06/03: Notice of the 13th Ordinary General Meeting of Shareholders

2016/05/11: Summary of Consolidated Financial Statements for the Year Ended March 31, 2016

: Company Information Index; President Message; Profile; Basic Philosophy; Production System; Reliability Assurance System; Financial Statementes

: Business Domain Index; Pharmaceuticals; Diagnostic Reagents; Medical Devices & Equipment; Overseas Sales; Fine Chemical Sales; Contract Manufacturing